Orthocell (ASX:OCC) has secured $30 million through an institutional placement to accelerate the global commercialisation of its flagship nerve repair…
Read More

Orthocell (ASX:OCC) has secured $30 million through an institutional placement to accelerate the global commercialisation of its flagship nerve repair…
Read More